Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in NSCLC

And extension to personalized prescription dose (RxRSI) and treatment optimization methods: https://t.co/zwMUJudrLu @IASLC 6/n

RT @CGrassberger: @joe_deasy @CTuscanoMD It’s the same argument made by @CancerConnector in the JTO paper below: there’s a wide range of ra…

@joe_deasy @CTuscanoMD It’s the same argument made by @CancerConnector in the JTO paper below: there’s a wide range of radiosensitivity, and for the sensitivity ⏫ patients increasing dose only leads to excess tox. impacting survival https://t.co/nxDCEZ…

@HenningWillers @jtorresroca @cd_fuller @BldCancerDoc @subatomicdoc @pipcosper @KimpleRandall @DrJohnSuh @ASTRO_org @BK_radiation and therefore could easily be washed away by toxicity changes. This is something we tried to address specifically in #lung…